High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
about
Acute lymphoblastic leukaemiaBlinatumomab: enlisting serial killer T-cells in the war against hematologic malignanciesTreating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristineUsing gene therapy to manipulate the immune system in the fight against B-cell leukemiasStimulating antitumor immunity with nanoparticlesDifferential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagyCD19-Targeted T Cells for Hematologic Malignancies: Clinical Experience to DateDrug delivery systems and combination therapy by using vinca alkaloidsChimeric antigen receptor T cells for sustained remissions in leukemiaEfficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemiaTreating adults with acute lymphocytic leukemia: new pharmacotherapy options.Clinical Translation of Nanomedicine.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Hispanic accrual on randomized cancer clinical trials: a call to arms.The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies.Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine.Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metforminA 50-year journey to cure childhood acute lymphoblastic leukemiaVincristine sulfate liposomal injection for acute lymphoblastic leukemia.Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature.Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure rates.Novel targeted therapies in acute lymphoblastic leukemia.B-cell antigen receptor signaling in chronic lymphocytic leukemia: therapeutic targets and translational opportunities.Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia.Emerging drugs for acute lymphocytic leukemia.Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies.New treatment options for chronic lymphocytic leukemia.Nanomedicine: a pharma perspective.Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development.The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.Are PEGylated liposomes better than conventional liposomes? A special case for vincristine.Structure, development, preclinical and clinical efficacy of blinatumomab in acute lymphoblastic leukemia.Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemiaHarnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directions.2-Anilino-3-Aroylquinolines as Potent Tubulin Polymerization Inhibitors.Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia.Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic Leukemia.
P2860
Q24602387-165A24AC-4D1C-4025-80D8-700CED431140Q26865838-3D2AD27F-1C34-41FA-BA61-9B98CE47251EQ27000078-2AEFA711-B3B6-43D6-99CB-26267C5EC3E4Q27011297-5DEE32A6-B293-4BB5-85EA-14AD6E9DC7CCQ27027780-6F83E0CB-1C40-45C3-B12F-D710BD31445DQ28081735-31F0FD35-3618-4962-963F-D2750DD0ACB3Q28083296-034A7D2F-49B9-425A-B20B-800AA7937422Q28829009-0BC11323-08B5-4622-8E0A-6FE2D51AF7CEQ29617588-8D5BA9B4-2599-4947-9637-557D40CBC797Q29617590-178E0ECA-E1ED-4BB5-936C-A26E6C484B18Q30243925-6092CC22-D93D-4EC6-81D6-769BB9F217C9Q30355939-FD7A3106-A931-49D6-87AD-60ECFEC48A10Q30366990-2C94013D-F396-4873-BE45-CD09677F2F18Q33729072-133136B7-6E87-4BFB-B941-A479A6BF6FF2Q33925422-7BEE76F8-4EEE-4043-AEE6-C8214356B79AQ35568576-54276B49-4F57-4E7D-9989-F2834D70926DQ36386891-C1277C50-29AA-4D1E-B14E-789B827EDE49Q36629939-775F7ECA-D3F5-4939-9BF9-3E7DDC4981A1Q36905125-C4709974-7FD7-4012-B83B-2410DF5F468CQ37166753-286F8853-5CAB-4DD2-8AF4-D8253B355E27Q37305758-8C38487C-9A5A-4C9F-897A-ED120A9E87DDQ37476694-842A82C6-F408-4E4F-BA06-31FE78DEEE42Q38095113-D3627E7B-FEB0-4652-AE5F-449426642247Q38120551-57D1FB70-9836-451D-BA65-32B54B708DAFQ38124119-A6660F6D-271E-4FED-9E20-E48BE29217D7Q38164108-14931676-3561-4A29-A651-E0D28EFF0762Q38172586-4A86426B-7EC3-4A79-86FC-416B8C1EC9E0Q38186752-8E440BEF-8304-4318-909B-8E65C0B0B91AQ38190095-09C82339-AE71-42B5-89C3-8AD1F6C69EB4Q38246663-3E39B986-3129-4AB4-89B5-49851F7D6829Q38282458-1F4701AF-F15E-41A1-8AE9-C0450CDFAC3AQ38328927-73A1A884-E738-4385-AE9D-EC381A026F89Q38507508-034E0EAC-EFF5-43B5-A948-7E95A827A6DBQ38527924-21CD5F66-B5B9-44BB-80EF-D6A82E0EA7F5Q38640263-11BEDBA0-B66E-4D5B-8E17-41C4AE529A7EQ38728592-6CFA8067-1316-4029-A6D5-30DE6B66E60CQ38755322-DC0C27CA-A1F8-4EE8-876A-619F65471066Q38813978-6E6CBF43-7E33-4102-8BB9-EEF10718FE4FQ38840423-5A67E894-8B4A-4320-B145-49F4A3687606Q38872343-CA49BCD5-0471-4A21-B123-FE1C018FE461
P2860
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
High-dose vincristine sulfate ...... acute lymphoblastic leukemia.
@en
High-dose vincristine sulfate ...... acute lymphoblastic leukemia.
@nl
type
label
High-dose vincristine sulfate ...... acute lymphoblastic leukemia.
@en
High-dose vincristine sulfate ...... acute lymphoblastic leukemia.
@nl
prefLabel
High-dose vincristine sulfate ...... acute lymphoblastic leukemia.
@en
High-dose vincristine sulfate ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
High-dose vincristine sulfate ...... acute lymphoblastic leukemia.
@en
P2093
Arnon Nagler
Deborah Thomas
Dina Ben-Yehuda
Gary Schiller
Guenter Schmieder
Jacob Rowe
Jeffrey A Silverman
John Lister
Karen Seiter
P2860
P304
P356
10.1200/JCO.2012.46.2309
P407
P577
2012-11-19T00:00:00Z